Skip to main content

Boniva IV FDA Approval History

FDA Approved: Yes (First approved January 6, 2006)
Brand name: Boniva IV
Generic name: ibandronate sodium
Dosage form: Injection
Company: Roche/GlaxoSmithKline
Treatment for: Osteoporosis

Boniva Injection is an intravenous formulation of the bisphosphonate drug ibandronate sodium, administered quarterly for the treatment of postmenopausal osteoporosis.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.